Paul Tudor Jones Magenta Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $179,809 - $234,047	-29,477 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.52 - $8.94 $30,793 - $42,223	-4,723 Reduced 13.81%	29,477 $200,000
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $211,356 - $367,992	34,200 New	34,200 $257,000
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $113,200 - $157,000	-10,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $135,000 - $145,200	10,000 New	10,000 $135,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.